中国医药导报
中国医药期刊欢迎您 今天是   2025年4月15日星期二
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床医学-内分泌 本期目录 | 过刊浏览 | 高级检索 |
木丹颗粒联合硫辛酸注射液治疗糖尿病足的临床效果
符芳盈1      陈玲1      翁育才1      陈金逸2
1.海南医学院第二附属医院药学部,海南海口   570311;
2.海南医学院第二附属医院内分泌科,海南海口   570311
Clinical efficacy of Mudan Granules combined with Thioctic Acid Injection in the treatment of diabetic foot#br#
FU Fangying1   CHEN Ling1   WENG Yucai1   CHEN Jinyi2
1.Department of Pharmacy, the Second Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou   570311, China; 
2.Department of Endocrine, the Second Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou   570311, China
全文: PDF (534 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 研究木丹颗粒联合硫辛酸注射液治疗糖尿病足的临床效果。 方法 选取2019年4月至2020年10月海南医学院第二附属医院收治的糖尿病足患者98例,通过随机数字表法将其分为对照组(硫辛酸注射液治疗)和试验组(对照组的基础上联合木丹颗粒治疗),各49例。两组均治疗4周。比较两组疗效,治疗前后血糖指标[糖化血红蛋白(HbA1c)、空腹血糖(FBG)、餐后2h血糖(2hPG)]、足背动脉血流动力学指标[血管内径、阻力指数(RI)、血流流速、搏动指数(PI)]、炎症因子指标[超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、降钙素原(PCT)]及不良反应发生率。 结果 试验组临床疗效高于对照组(P < 0.05)。治疗4周后,两组HbA1c、FBG、2hPG、hs-CRP、IL-6、PCT水平均较治疗前降低,且试验组低于对照组(P < 0.05)。两组治疗4周后血管内径、RI、血流流速、PI均较治疗前升高,且试验组高于对照组(P < 0.05)。两组不良反应发生率比较,差异无统计学意义(P > 0.05)。 结论 采用木丹颗粒和硫辛酸注射液治疗糖尿病足,效果确切,可有效控制血糖,改善炎症反应和足背动脉血流动力学,安全可靠。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
符芳盈1 陈玲1 翁育才1 陈金逸2
关键词 木丹颗粒硫辛酸注射液糖尿病足疗效不良反应    
Abstract:Objective To study the clinical effect of Mudan Granules combined with Thioctic Acid Injection in the treatment of diabetic foot. Methods A total of 98 patients with diabetic foot treated in the Second Affiliated Hospital of Hainan Medical College from April 2019 to October 2020 were selected. The patients were divided into control group (treated with Thioctic Acid Injection) and experimental group (treated with Mudan Granules on the basis of control group) by random number table method, with 49 cases in each group. The two groups were treated for 4 weeks. The curative effect, blood glucose index (glycosylated hemoglobin [HbA1c], fasting blood glucose [FBG], 2 h postprandial blood glucose [2hPG]), hemodynamic index of dorsalis pedis artery (vessel diameter, resistance index [RI], blood flow velocity, pulsatility index [PI]), inflammatory factor index (high sensitivity C-reactive protein [hs-CRP], interleukin-6 [IL-6], procalcitonin [PCT]) before and after treatment, and the incidence of adverse reactions were compared between the two groups. Results The clinical efficacy of the experimental group was higher than that of the control group (P < 0.05). After four weeks of treatment, the levels of HbA1c, FBG, 2hPG, hs-CRP, IL-6, and PCT decreased compared with before treatment in both groups, and those in the experimental group were lower than the control group (P < 0.05). After four weeks of treatment, the vascular diameter, RI, blood flow velocity, and PI increased compared with before treatment in both groups, and those in the experimental group were higher than the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion It is effective to treat diabetic foot with Mudan Granules and Thioctic Acid Injection. It can effectively control blood sugar, improve inflammatory reaction and hemodynamics of dorsal artery of foot, and is safe and reliable.
Key wordsMudan Granules    Thioctic Acid Injection    Diabetic foot    Curative effect    Adverse reaction
    
基金资助:海南省卫生和计划生育委员会卫生计生行业科研项目(18A201136)。
引用本文:   
符芳盈1 陈玲1 翁育才1 陈金逸2. 木丹颗粒联合硫辛酸注射液治疗糖尿病足的临床效果[J]. 中国医药导报, 2022, 19(3): 67-70.
FU Fangying1 CHEN Ling1 WENG Yucai1 CHEN Jinyi2. Clinical efficacy of Mudan Granules combined with Thioctic Acid Injection in the treatment of diabetic foot#br#. 中国医药导报, 2022, 19(3): 67-70.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2022/V19/I3/67

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司